Monitoring response to disease-modifying treatment in multiple sclerosis

Monitoring response to disease-modifying treatment in multiple sclerosis

Background: Standard criteria for defining suboptimal response to disease-modifying treatment (DMT) in patients with multiple sclerosis (MS) are lacking. Decision-making on how and when DMTs should be switched is challenging. The objective of the study was to identify areas of agreement on which and...

Full description

Bibliographic Details
Main Authors: J. Río, J. Peña, L. Brieva, J.M. García-Domínguez, A. Rodríguez-Antigüedad, C. Oreja-Guevara, L. Costa-Frossard, R. Arroyo
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Neurology Perspectives
Subjects:
Multiple sclerosis
suboptimal treatment response
MS management
MS treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S266704962300011X

Internet

http://www.sciencedirect.com/science/article/pii/S266704962300011X

Similar Items